EUVIMEDEUVIMED entdecken
Crossref

Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment

Alessandro Borghi, Maria Elena Flacco, Natale Schettini, Giulia Toni, Monica Corazza

Dermatology · 2024

DOI: 10.1159/000535849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology, 2024. Verfasst von Alessandro Borghi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Vulvar Lichen Sclerosus, Dyspareunia. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vulvar lichen sclerosus (VLS) is characterized by progressive anatomical changes which become increasingly severe and irreversible. The objective of this study was to investigate if a “window of opportunity” exists in VLS, i.e., to assess if an early treatment may prevent disease progression and facilitate clearance of symptoms and/or signs.

Methods

This retrospective, cohort study included VLS patients treated for the first time with a topical corticosteroid, namely with mometasone furoate 0.1% ointment, for 12 weeks (2016–2021). Scoring of subjective symptoms (global subjective score, GSS, and dyspareunia) and clinical features (global objective score [GOS] and sclerosis-scarring-atrophy) was performed at baseline (T0) and at the control visit (T1). We assessed if the achievement of clearance in GSS, GOS, sclerosis-scarring-atrophy, or dyspareunia depended on the time elapsed between VLS onset and treatment initiation.

Results

Among the 168 patients (59.2 ± 13.2 years) included, the median time between VLS onset and first treatment was 14.0 months. At T1, 48.8% of patients achieved clearance of GSS, 28% of GOS and 11.9% of both GSS and GOS, 57.9% of dyspareunia, and 19.2% of sclerosis-scarring-atrophy. The logistic regression model showed that each 10-month increase in treatment initiation adversely affected the clearance of GSS while starting treatment within 6 months of disease onset was significantly associated with clearance of GOS and sclerosis-scarring-atrophy.

Conclusion

Early treatment is crucial in determining a complete healing of VLS-related symptoms and signs, especially of tissue sclerosis-scarring-atrophy, which appear poorly responsive, or even unresponsive, after the earliest stages of the disease. Thus our findings provide evidence for a “window of opportunity” in VLS treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vulvar Lichen SclerosusDyspareuniaFemaleHumansCohort StudiesCicatrixRetrospective StudiesSclerosisTreatment OutcomeGlucocorticoidsAtrophy

Stichwörter der Autor:innen

ClearanceEarly treatmentTopical corticosteroidVulvar diseaseVulvar lichen sclerosusWindow of opportunity

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy.

Zitieren

APA

Borghi, A., Flacco, M. E., Schettini, N., Toni, G., & Corazza, M. (2024). Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment. Dermatology. https://doi.org/10.1159/000535849

Vancouver

Borghi A, Flacco ME, Schettini N, Toni G, Corazza M. Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment. Dermatology. 2024. doi:10.1159/000535849

BibTeX
@article{Borghi2024,
  author = {Borghi, Alessandro and Flacco, Maria Elena and Schettini, Natale and Toni, Giulia and Corazza, Monica},
  title = {Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment},
  journal = {Dermatology},
  year = {2024},
  doi = {10.1159/000535849}
}
Kostenlos starten →